Add to ORKGA-FABP predicts development of type 2 diabetes Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes- a 10-year prospective study in Chines
Serum FABPs and diabetic nephropathy Circulating levels of adipocyte and epidermal fatty acid-bindin...
OBJECTIVE - To investigate whether circulating levels of fibroblast growth factor 21 (FGF21), which ...
Background-—Obesity is closely associated with various cardiovascular diseases (CVDs). Adipose tissu...
OBJECTIVE — Adipocyte fatty acid–binding protein (A-FABP) is abundantly expressed in adipocytes and ...
Background: Diabetes mellitus is best described as a condition that is characterized by postprandial...
BACKGROUND - Adipocyte-fatty acid binding protein (A-FABP), a major cytoplasmic protein in adipocyte...
Introduction: Diabetes mellitus is acomplex metabolic disorder associated with increased risk of mic...
Background: Adipocyte-specific fatty acid-binding protein (A-FABP) is a cytoplasmic protein expresse...
Session: PP15-Novel Treatment for Diabetes - Focusing on GLP-1 and SGLT2 (Clinical)INTRODUCTION: Adi...
Background: Adipocyte fatty acid-binding protein (A-FABP) is traditionally thought to be a cytosolic...
Abstract Objective: Diabetic nephropathy (DN) is one of the most common and severe consequences...
Adipocyte fatty acid-binding protein (A-FABP) has been described as a novel adipokine, playing an im...
GADA positivity predicts diabetes in adults GADA positivity predicts non-insulin dependent diabetes ...
OBJECTIVE: To explore the relationship between plasma adipocyte fatty acid-binding protein (A-FABP),...
OBJECTIVE - To investigate the relationships of serum adipocyte fatty acid-binding protein (A-FABP) ...
Serum FABPs and diabetic nephropathy Circulating levels of adipocyte and epidermal fatty acid-bindin...
OBJECTIVE - To investigate whether circulating levels of fibroblast growth factor 21 (FGF21), which ...
Background-—Obesity is closely associated with various cardiovascular diseases (CVDs). Adipose tissu...
OBJECTIVE — Adipocyte fatty acid–binding protein (A-FABP) is abundantly expressed in adipocytes and ...
Background: Diabetes mellitus is best described as a condition that is characterized by postprandial...
BACKGROUND - Adipocyte-fatty acid binding protein (A-FABP), a major cytoplasmic protein in adipocyte...
Introduction: Diabetes mellitus is acomplex metabolic disorder associated with increased risk of mic...
Background: Adipocyte-specific fatty acid-binding protein (A-FABP) is a cytoplasmic protein expresse...
Session: PP15-Novel Treatment for Diabetes - Focusing on GLP-1 and SGLT2 (Clinical)INTRODUCTION: Adi...
Background: Adipocyte fatty acid-binding protein (A-FABP) is traditionally thought to be a cytosolic...
Abstract Objective: Diabetic nephropathy (DN) is one of the most common and severe consequences...
Adipocyte fatty acid-binding protein (A-FABP) has been described as a novel adipokine, playing an im...
GADA positivity predicts diabetes in adults GADA positivity predicts non-insulin dependent diabetes ...
OBJECTIVE: To explore the relationship between plasma adipocyte fatty acid-binding protein (A-FABP),...
OBJECTIVE - To investigate the relationships of serum adipocyte fatty acid-binding protein (A-FABP) ...
Serum FABPs and diabetic nephropathy Circulating levels of adipocyte and epidermal fatty acid-bindin...
OBJECTIVE - To investigate whether circulating levels of fibroblast growth factor 21 (FGF21), which ...
Background-—Obesity is closely associated with various cardiovascular diseases (CVDs). Adipose tissu...